Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are older than 15 years and 3 months
- You can be male or female
- You have been diagnosed with sickle cell disease (specifically the types known as HbSS or HbS-βthal0)
- You are covered by a social security/health insurance system
- You have freely agreed to take part and signed a consent form after being told about the study's purpose, process, and possible risks
- Your condition has been stable for at least 1 month since your last acute health event, or at least 3 months since your last blood transfusion
- You have been hospitalised at least once in the last 3 years due to a sickle cell pain crisis (vaso-occlusive crisis)
Who may not be able to join:
- The study team has concerns that you may have difficulty following the study's requirements
- You already do more than 1 hour of moderate physical activity per week on a regular basis
- You have an ongoing long-term inflammatory or infectious condition
- You have an unresolved health problem that started less than a month ago
- You were hospitalised for heart failure in the last 12 months
- You take blood-thinning medication, or you have a pacemaker or defibrillator
- You are currently pregnant or breastfeeding
- You are under a court order restricting your freedom, or you are under legal guardianship
- You are unable to understand the goals and conditions of the study or cannot give your consent (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of vaso-occlusive crises (VOCs) with hospitalisation; Exercise capacity and muscle metabolism and characteristics
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.